fitomenadiona
sgpharma pvt. ltd., mumbai., india - fitomenadiona - inyección im,iv - 1 mg/0.5 ml
fitomenadiona
nischi lifesciences, mahagujarat, india. - fitomenadiona - inyección im, iv - 1 mg/0,5 ml
vitamina k biol (fitomenadiona)
instituto biológico s.a.i.c., - fitomenadiona (vitamina k1) - solución inyectable im. - 1 mg
fitomenadiona solucion inyectable 10mg/1 ml
laboratorios sanderson s.a [cl] chile - fitomenadiona 10.00 mg - soluciÓn inyectable - cada ampolla contiene: fitomenadiona 10.00 mg + 10% exc
fitomenadiona 10 mg/ml emulsión inyectable
caplin point laboratories ltd. india - fitomenadiona 10 mg - emulsion inyectable - cada ml contiene: fitomenadiona 10 mg
fitomenadiona 10 mg/1ml solucion inyectable
laboratorios biosano s.a [cl] chile - fitomenadiona(vitamina k1) 10.00 mg - soluciÓn inyectable - cada ml contiene fitomenadiona(vitamina k1) (cas n° 84-80-0) 10.00 mg
palforzia
aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.
mibi institute of atomic energy 1 mg equipo de reactivos para preparacion radiofarmaceutica efg
narodowe centrum badan jadrowych - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de - equipo de reactivos para preparaciÓn radiofarmacÉutica - 1 mg - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de 1 mg - tecnecio (99mtc) sestamibi
zoonotic influenza vaccine seqirus
seqirus s.r.l. - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vacunas - active immunisation against h5 subtype of influenza a virus.
deltyba
otsuka novel products gmbh - delamanid - tuberculosis, resistente a múltiples fármacos - antimicobacterianos - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 y 5. se debe dar consideración a las directrices oficiales sobre el uso adecuado de agentes antibacterianos.